Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. - Wikidata - wikimedia - TriplyDB

Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.

Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.

http://www.wikidata.org/entity/Q34637194

about

Obesity and cancer Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer Obesity and cancer: mechanistic insights from transdisciplinary studies Why does obesity promote cancer? Epidemiology, biology, and open questions Diabetes and cancer: two diseases with obesity as a common risk factor Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies Body surface area formulae: an alarming ambiguity A Review of the Toxicologic Implications of Obesity Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: a retrospective review Body mass index and colorectal cancer prognosis: a systematic review and meta-analysis.Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study.Obesity and cancer pathogenesis.Prognostic factors in early breast cancer associated with body mass index, physical functioning, physical activity, and comorbidity: data from a nationwide Danish cohort.Reply to the letter to the editor 'Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study' by Daly et al.Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer.Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patients.Myelosuppression by chemotherapy in obese patients with gynecological cancers.Association of 15-hydroxyprostaglandin dehydrogenate and poor prognosis of obese breast cancer patients.Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation.Body mass index and weight change in relation to triple-negative breast cancer survival.The role of adipose tissue and obesity in causing treatment resistance of acute lymphoblastic leukemia.Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial Pharmacokinetics of Antimicrobials in Obese Children.Not All Body Surface Area Formulas Are the Same, but Does It Matter?The future of autologous stem cell transplantation in myeloma.The risk of colonic adenomas and colonic cancer in obesity Clinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality.Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer.Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation: a survey on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Aggressive estrogen-receptor-positive breast cancer arising in patients with elevated body mass index.Adjuvant chemotherapy dosing in low-income women: the impact of Hispanic ethnicity and patient self-efficacy.Nonalcoholic steatohepatitis in precision medicine: Unraveling the factors that contribute to individual variability.Impact of obesity on chemotherapy management and outcomes in women with gynecologic malignancies Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome.The impact of chemotherapy dose intensity and supportive care on the risk of febrile neutropenia in patients with early stage breast cancer: a prospective cohort study Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia Body Composition and Anti-Neoplastic Treatment in Adult and Older Subjects - A Systematic Review.

P2860

Q21558465-F73EB6BC-3830-410A-B757-067473CBD7D4 Q26775949-3DB2B431-1376-4844-85CF-93E7586748FB Q26786829-866F8793-28F9-4229-9C41-465011B32A6E Q26797301-38DCC497-28CB-4679-985F-CE0E23C570A4 Q26822753-85672936-578B-4B51-8973-EA82A598A287 Q27014939-B4ABEC08-1CAA-4343-A9A9-4AB072B9CABE Q27340024-36DFAE01-92B3-4083-8507-5B39BB9120D7 Q28082947-8DE1EB77-EFB8-4156-96A9-029D8D96ABBA Q28545175-33F5CD77-55B6-4FCE-B8FF-BFFD81F5ADCD Q30249342-3CEED228-6D4F-420E-B6AC-DA45D58699E2 Q30313786-CA935BDA-3D4F-4EBC-BE98-186357431E35 Q30361298-9851C60F-D2ED-40F2-8A05-CBF02CC149E5 Q31154302-BAD52C06-1E40-4243-AD62-D311B8EB259B Q32179246-81B66A0F-CDED-458A-BB6D-6EDAB0877AF9 Q33406415-41989515-D808-4337-B7D3-556BD17ED362 Q33418378-19527C32-A7EE-47F3-A07B-26C2D97467A7 Q33434316-63431099-7198-434A-9873-DA6FFB721EA1 Q33618485-D2BE5333-F80D-4DAF-BFB8-73C1FA562AF5 Q33697246-A1531A83-62C3-4667-BBFE-7132F78FFC31 Q33712501-61BAD469-8D2F-4FB0-A3F4-E4BF43EC96EE Q33714092-01E277FF-6842-410D-ABC6-9ABCCF97298E Q33841425-FC70BFA0-19B6-498B-83BC-3C028FF8335D Q33855312-FAACAB5A-134C-4D92-9BA2-83339448BF04 Q33859684-A23D3BC1-7EFD-44CC-BFBC-A92FC0418BD3 Q33917164-4C24E40A-7E96-4859-B24E-572F233E53C1 Q34157499-D650A4EE-9EF5-4039-B442-F3ABD5C55E4A Q34362184-92198383-1B82-41E4-8FE8-9FCE8192F5AF Q34428550-A90682B6-5C73-4148-9496-51E0F8B7E704 Q34598865-95AC1733-C2AA-4F34-99D0-D1E3C1B489DD Q34959952-EDC5C1BE-2CEA-4C42-852A-128D2648A04F Q35186057-28A8D09A-D56B-419D-A07F-AC8DF2C9E754 Q35492458-5C969C4E-3058-4DA0-9835-4B8A8ABD1374 Q35689076-272B186C-6B61-4D20-82B4-4B5EF60F8BA5 Q35748477-A7730BE3-8AF3-4EC7-9158-00DD27D22FFF Q35902270-5E95F3D6-429B-4068-A36B-16DF0B229103 Q35916166-B4E116F6-C116-4A93-AA04-75C7A61E4D52 Q36027025-29DADFB0-74EF-475D-93DB-6E4516395689 Q36053032-CC07EC11-8014-4997-A6AE-D635991DDAC6 Q36064889-F793051C-C839-4008-9D93-1B6C15B191BF Q36154581-1D49F832-98A4-4045-A204-89C1D4AAC171

P2860

Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.

http://www.wikidata.org/entity/Q34637194

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Appropriate chemotherapy dosin ...... y clinical practice guideline.

@ast

Appropriate chemotherapy dosin ...... y clinical practice guideline.

@en

Appropriate chemotherapy dosin ...... y clinical practice guideline.

@nl

type

label

Appropriate chemotherapy dosin ...... y clinical practice guideline.

@ast

Appropriate chemotherapy dosin ...... y clinical practice guideline.

@en

Appropriate chemotherapy dosin ...... y clinical practice guideline.

@nl

prefLabel

Appropriate chemotherapy dosin ...... y clinical practice guideline.

@ast

Appropriate chemotherapy dosin ...... y clinical practice guideline.

@en

Appropriate chemotherapy dosin ...... y clinical practice guideline.

@nl

P1433

Q34637194-D751A0D9-D87B-4E5D-ADA9-D4E11973C3CF

P1476

Q34637194-1E3BDB86-2D11-46A0-AB04-00FE765B667A

P2093

Q34637194-023EDD89-0490-47FA-ACF9-0C3FC6B86A9F

Q34637194-26D87B30-03F0-405C-A722-DC5493E5EE59

Q34637194-39B53695-C2C7-4E5B-8A6E-D675C6C184E4

Q34637194-3F82AD12-F319-42C3-8402-83211AD13A3B

Q34637194-4B2B102B-FF7C-47D3-98D2-B8A2A97BE625

Q34637194-8653CD9D-1766-4B98-BD88-38551309D6C6

Q34637194-8C790A0C-9EA9-435F-A31D-4BBC695EC622

Q34637194-93EA7939-D789-4F33-A368-E1050F09D0B5

Q34637194-BE59BC49-5466-47F1-AA81-FF330237053A

Q34637194-C7680E24-CC43-4A2D-BEAE-F98296551144

P304

Q34637194-5FF78AEB-4A86-4E14-B907-9BCFF0F54039

P31

Q34637194-73375DDC-68A3-40B7-9DA4-4E6948282CF7

P356

Q34637194-59D10082-0AD0-4D96-AE62-58792BAE2CB6

P407

Q34637194-1DBE972D-363C-48BB-9034-10D9A21BBE14

P433

Q34637194-E2698AB4-493D-4D30-9FEA-C529C7E04A11

P478

Q34637194-209FA460-DA2B-47A6-9AC5-929B21BB86B2

P50

Q34637194-53A74A01-292E-42C8-B562-04FD5DBF2E83

Q34637194-F543F331-C0F0-4B3A-BA90-37DC7A0BC156

P577

Q34637194-F6398263-3648-4345-ABAA-A57A79D23AFB

P698

Q34637194-726EDE07-4E57-45B8-AEF4-BE2E917952EF

P921

Q34637194-2EC0AEAF-48EC-4A9B-9A79-13C4143AA435

Q34637194-A1205BEE-1BDC-43D2-B76C-D75AA2272F7F

P356

JCO.2011.39.9436

P1433

Journal of Clinical Oncology

P1476

Appropriate chemotherapy dosin ...... y clinical practice guideline.

@en

P2093

Carolyn D Runowicz

http://www.w3.org/2001/XMLSchema#string

Edward P Balaban

http://www.w3.org/2001/XMLSchema#string

Gary H Lyman

http://www.w3.org/2001/XMLSchema#string

Gary L Rosner

http://www.w3.org/2001/XMLSchema#string

Holly Anderson

http://www.w3.org/2001/XMLSchema#string

James J Dignam

http://www.w3.org/2001/XMLSchema#string

Jennifer J Griggs

http://www.w3.org/2001/XMLSchema#string

Lara E Sucheston

http://www.w3.org/2001/XMLSchema#string

Michelle Shayne

http://www.w3.org/2001/XMLSchema#string

Pamela B Mangu

http://www.w3.org/2001/XMLSchema#string

P304

1553-1561

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2011.39.9436

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

American Society of Clinical Oncology

Alex Sparreboom

P577

2012-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22473167

http://www.w3.org/2001/XMLSchema#string

P921